Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Sigma Healthcare Limited (SIGGF)

2.0000
0.0000
(0.00%)
As of April 21 at 4:00:00 PM EDT. Market Open.
Loading Chart for SIGGF
  • Previous Close 2.0000
  • Open 2.0000
  • Bid 1.6500 x 313300
  • Ask 2.9100 x --
  • Day's Range 2.0000 - 2.0000
  • 52 Week Range 0.4000 - 2.9200
  • Volume 100
  • Avg. Volume 33
  • Market Cap (intraday) 23.087B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Mar 20, 2025
  • Forward Dividend & Yield 0.01 (0.33%)
  • Ex-Dividend Date Oct 1, 2024
  • 1y Target Est --

Sigma Healthcare Limited operates as a pharmaceutical wholesaler, distributor, and pharmacy franchisor in Australia and internationally. It offers intellectual property and support services to stores operating under the Chemist Warehouse, My Chemist, Amcal, and Discount Drug stores. The company owns retail pharmacies; and provide retail support services to network of pharmacy members, dose administration aid services, and the provision of third- and fourth-party logistics services to pharmaceutical manufacturers and other supplier partners. Further, the company offers products online. The company was founded in 1912 and is headquartered in Clayton, Australia.

sigmahealthcare.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: SIGGF

View More

Performance Overview: SIGGF

Trailing total returns as of 4/22/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

SIGGF
7.53%
S&P/ASX 200 [XJO] (^AXJO)
4.20%

1-Year Return

SIGGF
402.90%
S&P/ASX 200 [XJO] (^AXJO)
2.19%

3-Year Return

SIGGF
257.38%
S&P/ASX 200 [XJO] (^AXJO)
4.60%

5-Year Return

SIGGF
257.38%
S&P/ASX 200 [XJO] (^AXJO)
49.71%

Compare To: SIGGF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SIGGF

View More

Valuation Measures

Annual
As of 4/21/2025
  • Market Cap

    21.91B

  • Enterprise Value

    21.98B

  • Trailing P/E

    --

  • Forward P/E

    66.23

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.01

  • Price/Book (mrq)

    43.26

  • Enterprise Value/Revenue

    7.05

  • Enterprise Value/EBITDA

    622.26

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    16.42%

  • Return on Assets (ttm)

    13.56%

  • Return on Equity (ttm)

    98.42%

  • Revenue (ttm)

    3.29B

  • Net Income Avi to Common (ttm)

    541.01M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    58.4M

Research Analysis: SIGGF

View More

Company Insights: SIGGF

Research Reports: SIGGF

View More